III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52 , 20246, Hamburg, Germany.
Division of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Cell Tissue Res. 2021 Aug;385(2):423-434. doi: 10.1007/s00441-021-03454-3. Epub 2021 Apr 27.
Focal segmental glomerulosclerosis (FSGS) represents a glomerular scar formation downstream of various different mechanisms leading to podocytopathy and podocyte loss. Recently, significant advances were made in understanding genetic factors, podocyte intrinsic mechanisms, and adaptive mechanisms causing FSGS. However, while most cases of nephrotic FSGS are being treated with immunosuppressants, the underlying immune dysregulation, involved immune cells, and soluble factors are only incompletely understood. Thus, we here summarize the current knowledge of proposed immune effector cells, secreted soluble factors, and podocyte response in immune-mediated (primary) FSGS.
局灶节段性肾小球硬化症 (FSGS) 代表了各种不同机制导致的足细胞病和足细胞丢失的肾小球瘢痕形成。最近,在理解遗传因素、足细胞内在机制和导致 FSGS 的适应性机制方面取得了重大进展。然而,尽管大多数肾病性 FSGS 病例都在用免疫抑制剂治疗,但潜在的免疫失调、涉及的免疫细胞和可溶性因子仅部分被理解。因此,我们在这里总结了目前关于免疫介导的(原发性)FSGS 中拟议的免疫效应细胞、分泌的可溶性因子和足细胞反应的知识。